Flexible Design: Custom and Partnered Data Sources
BullFrog Data Networks® extend the bfLEAP™ platform to create purpose-built comprehensive data networks from multimodal data to identify hidden insights. Networks can be created using clinical trial data, EMR, claims, “-omics” data, and all types of real-world data (RWD).
Oncology Focus:
The first product offering through BullFrog Data Networks® leverages a leading cancer genomics data set with over 20,000 primary cancer and matched normal samples including genomic, epigenomic, transcriptomic, and proteomic data. BullFrog Data Networks® aim to allow stakeholders to derive novel insights toward target identification and validation, understanding mechanism of action, clinical trial optimization, drug repurposing, and more. BullFrog Data Networks® outputs from the following indications are available (please contact us for additional information):
- Acute myeloid leukemia
- Adrenocortical carcinoma
- Bladder urothelial carcinoma
- Breast ductal carcinoma
- Breast lobular carcinoma
- Cervical carcinoma
- Cholangiocarcinoma
- Colorectal adenocarcinoma
- Esophageal carcinoma
- Gastric adenocarcinoma
- Glioblastoma multiforme
- Head and neck squamous cell carcinoma
- Hepatocellular carcinoma
- Chromophobe renal cell carcinoma
- Clear cell renal cell carcinoma
- Papillary renal cell carcinoma
- Lower grade glioma
- Lung adenocarcinoma
- Lung squamous cell carcinoma
- Mesothelioma
- Ovarian serous adenocarcinoma
- Pancreatic ductal adenocarcinoma
- Paraganglioma & pheochromocytoma
- Prostate adenocarcinoma
- Sarcoma
- Skin cutaneous melanoma
- Testicular germ cell cancer
- Thymoma
- Thyroid papillary carcinoma
- Uterine carcinosarcoma
- Uterine corpus endometrioid carcinoma
- Uveal melanoma
